Grewia tenax-Mediated Silver Nanoparticles as Efficient Antibacterial and Antifungal Agents

Table 4

Quantitative estimation of biofilm inhibition (percentage) by crystal violet assay against Gram-positive and Gram-negative bacterial strains.

Bacterial strains	GTAgNP concentrations (μg)
	0.25	0.5	0.75	1
P. aeruginosa	7.7 ± 0.477109	14.7 ± 1.030016	26.5 ± 0.725902	32.9 ± 0.484974
S. aureus	12.8 ± 1.017988	22.5 ± 1.053565	31.6 ± 0.796576	36.4 ± 0.29023
E. coli	15.5 ± 1.017988	24.8 ± 1.053565	37.4 ± 0.796576	42.1 ± 0.29023
B. subtilis	14.7 ± 0.830682	22.3 ± 0.522047	27.5 ± 0.945163	33.8 ± 0.550757